Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions.

[1]  E. Rybicki,et al.  Insights into the role and function of L2, the minor capsid protein of papillomaviruses , 2009, Archives of Virology.

[2]  Y. Ishii,et al.  Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. , 2007, Virology.

[3]  J. Moroianu,et al.  The L2 Minor Capsid Protein of Human Papillomavirus Type 16 Interacts with a Network of Nuclear Import Receptors , 2004, Journal of Virology.

[4]  D. Lowy,et al.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Lowy,et al.  Efficient Intracellular Assembly of Papillomaviral Vectors , 2004, Journal of Virology.

[6]  R. Garcea,et al.  Interactions between Papillomavirus L1 and L2 Capsid Proteins , 2003, Journal of Virology.

[7]  Xiaomin Zhao,et al.  Specific Inactivation of Inhibitory Sequences in the 5′ End of the Human Papillomavirus Type 16 L1 Open Reading Frame Results in Production of High Levels of L1 Protein in Human Epithelial Cells , 2002, Journal of Virology.

[8]  P. Beard,et al.  Infectious human papillomavirus type 18 pseudovirions. , 1998, Journal of molecular biology.

[9]  M. Jellne,et al.  mRNA Instability Elements in the Human Papillomavirus Type 16 L2 Coding Region , 1998, Journal of Virology.

[10]  M. Sapp,et al.  Generation and neutralization of pseudovirions of human papillomavirus type 33 , 1997, Journal of virology.

[11]  I. Frazer,et al.  Sequences required for the nuclear targeting and accumulation of human papillomavirus type 6B L2 protein. , 1995, Virology.

[12]  T. Matsukura,et al.  Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions , 1995, International journal of cancer.

[13]  I. Frazer,et al.  Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. , 1991, Virology.

[14]  C. Crum,et al.  Biologic properties and nucleotide sequence analysis of human papillomavirus type 51 , 1991, Journal of virology.

[15]  G. Nuovo,et al.  Isolation of a novel human papillomavirus (type 51) from a cervical condyloma , 1988, Journal of virology.

[16]  D. Lowy,et al.  Generation of HPV pseudovirions using transfection and their use in neutralization assays. , 2005, Methods in molecular medicine.

[17]  H. Selinka,et al.  Pseudovirions as specific tools for investigation of virus interactions with cells. , 2005, Methods in molecular biology.